Chief Legal & Corp Affairs Officer of $AVGO sells 25,921 shares in insider sale

Mark David Brazeal, serving as the Chief Legal & Corp Affairs Ofc of $AVGO, recently made headlines by selling 25,921 shares of the company on 12-26-2025, totaling an estimated $9,126,058. This transaction represented a significant portion of about 9.7% of their shares in this class of stock. Post this sale, Brazeal currently holds 240,573 shares in this class of $AVGO stock.

Digging deeper into the $AVGO insider trading activities, it reveals a pattern of transactions over the last six months. The key players like Henry Samueli, Hock E Tan, Mark David Brazeal, Kirsten M. Spears, Charlie B Kawwas, Justine Page, and Harry L. You have partaken in various trades. While Henry Samueli has not made any purchases but sold 689,113 shares, netting approximately $252,917,774, Hock E Tan has similarly not acquired any shares but sold 478,154, making around $160,784,807. On the other hand, Mark David Brazeal, in addition to the recent sale, has conducted a total of 59 sales, disposing of 115,933 shares worth $39,622,559. Similarly, Kirsten M. Spears and Charlie B Kawwas have engaged in selling activities, shedding 18,412 shares for $6,372,620 and 9,560 shares for $3,309,571, respectively. While Justine Page sold 4,800 shares for $1,587,952, Harry L. You stands out as the only insider with purchase activities, buying 4,550 shares for $1,552,999.

Continuing the exploration of $AVGO, it comes as no surprise that 2,034 institutional investors have added shares of $AVGO stock to their portfolio, with 1,836 reducing their positions in the most recent quarter. Notable moves include UBS AM boosting their holdings by 31,423,170 shares, which translates to 78.8%, valued at $10,366,818,014. In contrast, Capital World Investors saw a decrease in their shares by 12,713,939, representing an 8.6% dip, amounting to $4,194,455,615. Additionally, Wellington Management Group LLP, BNP Paribas Financial Markets, Bank of America Corp /DE/, and Price T Rowe Associates Inc /MD/ have made significant alterations to their $AVGO stock portfolios.

In terms of revenue, $AVGO showcased an impressive figure with revenues amounting to $18B in Q4 2025, marking a substantial 28.18% surge compared to the same period in the previous year. Interested parties can monitor AVGO’s financial performance on Quiver Quantitative’s AVGO stock page.

Furthermore, congressional members have actively traded $AVGO stock, with 18 transactions recorded in the past six months. Noteworthy is Representative Cleo Fields, engaging in six purchases totaling up to $315,000, alongside other Congress members like Representative Gilbert Ray Cisneros, Jr., Representative Lisa C. McClain, Representative Jared Moskowitz, Representative Val T. Hoyle, Senator Shelley Moore Capito, Representative Ritchie Torres, and Representative James Comer contributing to the trading activity.

Additionally, Wall Street analysts have been closely observing $AVGO, issuing various ratings on the stock. With 16 firms endorsing buy ratings and none advocating sell ratings, the sentiment around $AVGO remains positive in the market. Recent reports from Benchmark, Bernstein, Rosenblatt, Oppenheimer, Mizuho, Piper Sandler, and Morgan Stanley have all reiterated favorable outlooks on the stock.

In conclusion, $AVGO has made significant strides in various aspects, including insider trading, institutional investments, revenue growth, congressional trading, analyst ratings, and price targets. Investors and stakeholders keen on tracking $AVGO’s trajectory can utilize Quiver Quantitative’s comprehensive platforms for detailed insights and market analysis.